论文著作：
1.Design, synthesis, and antiviral activity of 1-aryl-4-arylmethylpiperazine derivatives as Zika virus inhibitors with broad antiviral spectrum. Bioorg. Med. Chem. 2024, 103, 117682.
2.Design, synthesis and biological evaluation of 2-((4-sulfamoylphenyl)amino)-pyrrolo[2,3-d]pyrimidine derivatives as CDK inhibitors. J Enzyme Inhib Med Chem. 2023, 38(1), 2169282.
3.Identification of an N-phenylsulfonyl-2-(piperazin-1-yl)methyl-benzonitrile derivative as Zika virus entry inhibitor. Bioorg Chem. 2023, 130, 106265.
4.Repurposing of the antihistamine mebhydrolin napadisylate for treatment of Zika virus infection. Bioorg Chem. 2022, 128, 106024.
5.Design, Synthesis, and Biological Evaluation of 2-((4-Bisarylmethyl-piperazin-1-yl)methyl)benzonitrile Derivatives as HCV Entry Inhibitors. J Med Chem. 2022, 65, 2107–2121
6.Design, synthesis, and biological evaluation of 2,6,7-substituted pyrrolo[2,3-d]pyrimidines as cyclin dependent kinase inhibitor in pancreatic cancer cells. Bioorg Med Chem Lett. 2021, 33, 127725.
7.2-((4-Arylpiperazin-1-yl)methyl)benzonitrile Derivatives as Orally Available Inhibitors of Hepatitis C Virus With a Novel Mechanism of Action. J Med Chem. 2020, 63, 5972-5989.
8.Design, Synthesis, and Evaluation of Novel 4-amino-2-(4-benzylpiperazin-1-yl)methylbenzonitrile Compounds as Zika Inhibitors. Bioorg Med Chem Lett. 2020, 30, 126906.
9.Synthesis and Broad Antiviral Activity of Novel 2-aryl-isoindolin-1-ones towards Diverse Enterovirus A71 Clinical Isolates. Molecules. 2019, 24(5), E985.
李艳萍
北京市
研究领域：
生物医药
研究方向：
新型小分子抗病毒药物发现
所在单位：
中国医学科学院北京协和医学院
